In their studies, Singh et al. [47] stratified K-RAS mutant pancreatic and lung cancer cell lines into K-RAS-dependent or K-RAS-independent subtypes, according to the ability of K-RAS to support cell viability. This evidence concerns the gene KRAS and lung cancer.